A delegation from Houston consisting of former astronauts, aircraft experts, and local leaders were invited to the Paris Air Show to represent the Space City. Photo courtesy of the Greater Houston Partnership

Houston takes flight at Paris Air Show just in time for Space City Month​

Oui, oui

As we move closer to the 50th anniversary of Apollo 11 in mid-July, eyes around the world are turning to the United States and to Houston's NASA Johnson Space Center in celebration of the historic mission that first brought mankind to the moon. Thanks to that unprecedented interest, Houston was asked to be a featured partner of the USA Partnership Pavilion at the Paris Air Show last month.

Drawing nearly 2,500 exhibitors from 49 countries and more than 316,000 total visitors, the Paris Air Show continues to be the world's premier aerospace and aviation industry event. Houston's historic achievements set the stage to showcase how the region continues to be a global hub for technology and innovation.

A delegation of top Houston organizations brought distinct assets that showcased a collective advantage in competing for aerospace business. Led by the Greater Houston Partnership under the promotional banner Space City: The Gateway to Innovation, the group included:

  • Houston Spaceport, one of the nation's 10 licensed commercial spaceports co-located at Ellington Field (EFD).
  • Rice Space Institute, which has helped to establish Rice University's international reputation in all areas of space research by investing in efforts to further the development of new ideas and innovation in the broad area that is space exploration and utilization.
  • SpaceCom, the Space Commerce Conference and Exposition, an annual two-day conference that connects NASA technology with the private sector to fuel future innovation
  • Space Center Houston, the official visitor center of NASA's Johnson Space Center and a leading science and space learning center.
  • Blue Bear Capital, a Houston-based venture capital firm investing in fast-growing private companies that apply data driven technologies and innovative business models to the global energy supply chain.
  • Trumbull Unmanned, A Forbes Top 25 Veteran Founded startup based out of the Houston Spaceport that collects, analyzes, and visualizes critical data for the energy sector, primarily supporting oil and gas and environmental efforts.

As an anchor NASA community and home to the sharpest minds in aerospace, life sciences, energy and innovation, it was only fitting that Houston have a prominent presence in the show at Le Bourget. Among the 300 exhibitors representing the United States in the USA Partnership Pavilion, twenty of which were states, Houston was the only city with a major presence. Throughout the week, the Houston delegation participated in a schedule of high-profile thought-leadership and hospitality events to engage and educate global industry and government decision-makers and influencers.

For our part at the Greater Houston Partnership, we were able to conduct a series of meetings with companies from around the world, gathering more than 40 international and domestic economic development leads. The show is also a great media opportunity that allowed us to secure nearly 20 interviews for our delegation members with print and broadcast outlets from across the U.S. and Europe.

The USA Partnership Pavilion's week-long celebration of innovation and human achievement was led Apollo Astronauts Brig. Gen. Charlie Duke, and Houston-natives Col. Walt Cunningham and Col. Al Warden. Their presence served as a tangible way to connect our nation's achievements to the innovative future of the global aerospace industry.

"The 50th anniversary is such a unique time in history. It gives us an opportunity to think back about what we did, realize where we are today, and where we want to be in the future," says Col. Al Worden, "The most important thing about the space program was not so much about putting a man on the moon, it was about developing the technology to get there. Those technologies have made this country so successful, and I hope we continue to see that type of commitment to technology development in the future."

Houston delegates were asked to participate in several thought leadership panels.

"As we continue to explore further into the universe, there are a myriad of technical challenges that need to be overcome," says David Alexander, director of Rice Space Institute, who moderated a panel discussion on advancing technologies that will help humans physically and mentally adapt to deep space exploration. He was joined by industry leaders from United Launch Alliance (ULA), Lockheed Martin, Virgin Galactic, and Harris Corporation for the conversation centered around the use of artificial intelligence, 3D printing and additive manufacturing.

Governments around the globe including those in Europe, China and of course the United States have accelerated a discussion about sending humans back to the moon as a key step in our continued human exploration of deep space. This concept is also proving attractive to private companies, with an increase in public-private partnerships and a broader role being played by commercial entities in government aspirations.

Former astronaut and Space Station Commander turned venture capital leader Tim Kopra participated in a panel discussion on this very topic alongside representative from United Launch Alliance (ULA), the Federal Aviation Administration (FAA), Lockheed Martin, Deloitte, and the U.S. Air Force. Although Kopra's Blue Bear Capital's primary target are data-driven technologies in the energy industry, he notes that "there are a lot of intersections between energy and aerospace, and Houston's melting pot of global industries has turned the region into a hot bed for innovation with broader application of technologies."

The centerpiece of the Houston delegation's presence at the Paris Air Show was an executive briefing on June 19 featuring keynote remarks from Kopra that helped set the tone for the work Houston continues to do in innovation and aerospace technology. Kopra discussed his background with NASA, the transition into the funding scene that supports the region's growing innovation ecosystem, and what Houston has to offer businesses looking to expand their operations in the areas of aerospace, manufacturing, and digital technology.

A panel discussion followed, addressing topics that included educating the next generation of engineers and explorers, the intersection of NASA technology and the private sector, the next frontier of space exploration and the unique position that Houston has in pioneering those efforts.

"Over the past 58 years, Johnson Space Center has led the U.S. and the world in human exploration, discovery, and achievement in space," Kopra tells the audience. "Now we are in a position of transitioning a lot of those capabilities into the civilian sector."

The Houston Spaceport is one big step in that ongoing evolution. As the only commercial spaceport in the nation centered in a large metropolitan area, the Houston facility will have unmatched access to resources for companies and operators, said Arturo Machuca, general manager of the spaceport.

"The Houston Spaceport is being developed to ensure Houston stays relevant in commercial aerospace and aviation activities," he says. "Houston continues to hold a strong value proposition for companies looking to enter the aerospace industry with a unique set of advantages including the proximity to NASA's Johnson Space Center, unparalleled infrastructure through the Houston Airport System, and a strong talent base."

------

Josh Davis is the director of International Investment and Trade at the Greater Houston Partnership and organized the Partnership's participation at the Paris Air Show and gathered the delegation.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.